Skip to Content

Delzicol Approval History

  • FDA approved: Yes (First approved February 1st, 2013)
  • Brand name: Delzicol
  • Generic name: mesalamine
  • Dosage form: Delayed-Release Capsules
  • Company: Allergan plc
  • Treatment for: Ulcerative Colitis

Delzicol (mesalamine) is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Development History and FDA Approval Process for Delzicol

Feb  6, 2013Approval Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.